Albumin and heparin multilayer coatings for blood-contacting medical devices

Journal of Biomedical Materials Research

Volumn 51, Issue 2, 2000, Pages 249-257

  Brynda, Eduard ^a   Houska, Milan ^a   Jiroušková, Markéta ^b   Dyr, Jan E ^b  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Adsorption of plasma proteins; Albumin heparin multilayer coatings; In vivo durability; Interaction with platelets

Indexed keywords

BLOOD; CELLS; POLYSTYRENES; PROSTHETICS; PROTEINS; TRANSPLANTATION (SURGICAL);

ANTITHROMBIN; FIBRINOGEN; HEPARIN; HUMAN SERUM ALBUMIN; VASCULAR PROSTHESES;

BIOMEDICAL EQUIPMENT;

ALBUMIN; HEPARIN;

ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; BLOOD VESSEL PROSTHESIS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ADSORPTION; ANIMALS; ANTITHROMBIN III; BIOCOMPATIBLE MATERIALS; BLOOD; BLOOD PLATELETS; BLOOD VESSEL PROSTHESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN; GOATS; HEPARIN; HUMANS; IMMUNOGLOBULIN G; PROSTHESIS DESIGN; SERUM ALBUMIN;

EID: 0034041194     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(200008)51:2<249::AID-JBM14>3.0.CO;2-X     Document Type: Article

References (31)

1. Coleman RW, Hirsh J, Marder VJ, Salzman EW, editors. Hemostasis and thrombosis: Basic principles and clinical practice. 3rd ed. Philadelphia: J.B. Lippincott Company; 1994.
2. Andrade JD, Hlady VL, Van Wagenen RL. Effects of plasma protein adsorption on protein conformation and activity. Pure Appl Chem 1984;56:1345-1350.
3. Scott FC. Mechanism of the participation of contact system in the Vroman. Review and summary. J Biomater Sci, Polym Edn 1991;2:173-181.
4. Savage B, Shattil SJ, Ruggery ZM. Modulation of platelet function through adhesion receptors: A dual role for glycoprotein IIbIIIa mediated by fibrinogen and glycoprotein Ib - von Willebrand factor. J Biol Chem 1992;267:11300-11306.
5. Salzman E, Merril E, Kent K. Interaction of blood with artificial surfaces. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and thrombosis. Edinborough: Churchill Livingstone; 1994. p 1469-1485.
6. Elam JH, Nygren H. Adsorption of coagulation proteins from whole blood onto polymer materials: Relation to platelet activation. Biomaterials 1992;13:3-8.
7. Blombäck B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275:501-515.
8. Saito H. The contact phase of blood coagulation. In: Haemostasis and thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Edinborough: Churchill Livingstone; 1994. p 289-307.
9. Lane DA, Lindahl U, editors. Heparin, chemical and biological properties, clinical applications. London: Edward Arnold; 1989.
10. Boshkov LK, Warkentin TE, Hayward CPM, Andrew M, Kelton JG. Heparin-induced thrombocytopenia and thrombosis: Clinical and laboratory studies. Br J Haematol 1993;84:322-328.
11. Wright TC, Castellot JJ, Diamond JR, Karnovsky MJ. Regulation of cellular proliferation by heparin and heparin sulphate. In: Lane DA, Lindahl U, editors. Heparin, chemical and biological properties, clinical applications. London: Edward Arnold; 1989.
12. Kottke-Merchant K, Anderson JM, Umemura Y, Merchant RE. Effect of albumin coating on the blood compatibility of Dacron arterial prostheses. Biomaterials 1989;10:147-155.
13. Amiji M, Park H, Park K. Study on prevention of surface-induced platelet activation by albumin coating. J Biomater Sci, Polym Edn 1992;3:375-388.
14. DeQueiroz AAA, Barrak ER, Gil, HAC, Higa, OZ. Surface studies of albumin immobilized onto PE and PVC films. J Biomater Sci. Polym Edn 1997;8:667-681.
15. Bennett J, Hill J, Bruhn P, Long W, Parson J. Heparin-free cardiopulmonary support, utilizing a Carmeda-coated circuit, for a patient with pulmonary haemorrhage and multiple trauma. J Extra-Corp Tech 1992;23:86-89.
16. Urlesberger B, Zobel G, Rodl S, Dacar D, Friehs I, Leschink B, Muntean W. Activation of the clotting system: Heparin-coated versus noncoated systems for extracorporeal. Int J Artif Org 1997;20:708-712.
17. Nojiri C, Kido T, Sugiama T, Horiuchi K, Kijima T, Toshihiko HK, Kuribayhashi E, Nogava A, Ogiwara K, Akutsu K. Can heparin-immobilized surfaces maintain nonthrombogenic activity during in vivo long-term implantation. Am Soc Artif Intern Org J 1996;42:M468-M475.
18. Sanchez J, Elque G, Risenfeld J, Olson P. Control of contact activation on end-point immobilized heparin: The role of antithrombin and the specific antithrombin-binding sequence. J Biomed Mater Res 1995;29:655-661.
19. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Org 1983;11:161-163.
20. Engbers GHM, Dost L, Hennink WE, Aarts PAMM, Sixma JJ, Feijen J. Platelet adhesion studies onto albumin-heparin conjugate-coated catheters. Life Support. Syst 1986;4:416-418.
21. Hennink WE, Dost L, Feijen J, Kim SW. Interaction of albumin-heparin conjugate preadsorbed surfaces with blood. Trans Am Soc Artif Intern Org 1983;29:200-205.
22. Brynda E, Houska M. Multiple alternating molecular layers of albumin and heparin on solid surfaces. J Colloid Interface Sci 1996;183:18-25.
23. Houska M, Brynda E. Interaction of proteins with polyelectrolytes at solid/liquid interfaces: Multiple alternating molecular layers of albumin and heparin. J Colloid Interface Sci 1997;188: 243-250.
24. Brynda E, Houska M. Preparation of organized protein multilayers. Macromol Rapid Comm 1998;19:173-176.
25. Dyr JE, Cajthamlová H, Suttnar J, Stockbauer P, Hrkal Z. Monoclonal antibodies directed against different neoepitopes expressed during lysis of human cross-linked fibrinogen. In: Thrombosis and haemorrhagic disorders. Sinzinger H, Vinazzer H, editors. Wurzburg: Schmidt and Meyer GmbH; 1989. p 166-171.
26. Hrkal Z, Cajthamlová H, Novák JJ, Paluska E, Stöckbauer P. Monoclonal antibodies against human antithrombin III. Hybridoma 1991;10:633-640.
27. Fiala V, Šotolová V, Urbánek P, Vašku° J, Lukáš J, Houska M, Tyráčková V. Hemocompatibility of segmented polyurethanes investigated in vivo. Biomaterials 1987;8:259-254.
28. Brynda E, Homola J, Houska M, Pfeifer P, škvor J. Antibody networks for surface plasmon resonance immunosensors. Sensors Actuators Bull 1999;54:132-136.
29. th Vienna Opt(r)ode workshop, Prague, October 7-8, 1998.
30. Cheung AK, Parker CJ, Janatova J, Brynda E. Modulation of complement activation on hemodialysis membranes by immobilized heparin. J Am Soc Nephrol 1992;2:1328-1337.
31. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980;65:64-73.